Science Explorer Back to mapMap

Most cited papers from Alzheimer's Association

What are the most cited papers from Alzheimer's Association?

The most cited paper from Alzheimer's Association is "The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease" (Guy M. McKhann, David S. Knopman, Howard Mark Chertkow et al., 2011), with 19,132 citations. Next come "NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease" (10,885) and "The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease" (10,419).

Showing 50 of 60 papers. Every paper with more than 386 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Guy M. McKhann, David S. Knopman, Howard Mark Chertkow et al. · Alzheimer s & Dementia Open access 22 Apr 2011 19,132
2 NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease Clifford R. Jack et al. · Alzheimer s & Dementia Open access Apr 2018 10,885
3 The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Marilyn S. Albert, Steven T. DeKosky, Dennis W. Dickson et al. · Alzheimer s & Dementia Open access 22 Apr 2011 10,419
4 Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Reisa Anne Sperling et al. · Alzheimer s & Dementia Open access 22 Apr 2011 7,286
5 Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing Brian W. Kunkle et al. · Nature Genetics ReviewOpen access469 authors 28 Feb 2019 3,277
6 National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease Bradley T. Hyman, Creighton H. Phelps, Thomas G. Beach et al. · Alzheimer s & Dementia Open access 2012 3,246
7 Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup Clifford R. Jack, Jeffrey Scott Andrews, Thomas G. Beach et al. · Alzheimer s & Dementia Open access 27 Jun 2024 2,670
8 Introduction to the recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Clifford R. Jack, Marilyn Albert, David S. Knopman et al. · Alzheimer s & Dementia Open access 22 Apr 2011 2,073
9 Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease Adam Christian Naj et al. · Nature Genetics Open access155 authors 3 Apr 2011 2,024
10 Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria Bruno Dubois et al. · Alzheimer s & Dementia Open access Mar 2016 1,953
11 Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population‐based perspective Matthew Baumgart, Heather M. Snyder, María C. Carrillo et al. · Alzheimer s & Dementia Open access 31 May 2015 1,696
12 Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia Willemijn J. Jansen et al. · JAMA Open access129 authors 19 May 2015 1,662
13 Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders Sebastian Palmqvist et al. · JAMA Open access 28 Jul 2020 1,657
14 Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis Yasser Iturria‐Medina et al. · Nature Communications Open access316 authors 21 Jun 2016 1,244
15 Neuropsychiatric symptoms in Alzheimer's disease Constantine G. Lyketsos, María C. Carrillo, J. Michael Ryan et al. · Alzheimer s & Dementia Open access Sep 2011 1,159
16 Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease Rebecca C. Sims et al. · Nature Genetics Open access450 authors 17 Jul 2017 1,122
17 Nonpharmacological Therapies in Alzheimer’s Disease: A Systematic Review of Efficacy Javier Olazarán et al. · Dementia and Geriatric Cognitive Disorders Review 2010 940
18 Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection Tanayott Thaweethai et al. · JAMA Open access825 authors 25 May 2023 881
19 Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup Reisa Anne Sperling, Clifford R. Jack, Sandra E. Black et al. · Alzheimer s & Dementia Open access Jul 2011 859
20 Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease Eric M. Reiman, Kewei Chen, Xiaofen Liu et al. · Proceedings of the National Academy of Sciences Open access 3 Apr 2009 804
21 Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI Susan M. Landau, Danielle Jenine Harvey, Cindee M. Madison et al. · Neurobiology of Aging Open access 6 Aug 2009 775
22 Multiscale Analysis of Independent Alzheimer’s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus Ben Readhead, Jean‐Vianney Haure‐Mirande, Cory C. Funk et al. · Neuron Open access 21 Jun 2018 746
23 New insights into atypical Alzheimer's disease in the era of biomarkers Jonathan Graff‐Radford, Keir X. X. Yong, Liana G. Apostolova et al. · The Lancet Neurology Open access 18 Feb 2021 701
24 Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease Michael F. Egan, James T. Kost, Pierre N. Tariot et al. · New England Journal of Medicine Open access 2 May 2018 701
25 Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia Gil D. Rabinovici, Constantine A. Gatsonis, Charles S. Apgar et al. · JAMA Open access 2 Apr 2019 686
26 Prevalence of Amyloid PET Positivity in Dementia Syndromes Rik Ossenkoppele et al. · JAMA Open access 19 May 2015 682
27 Consensus classification of posterior cortical atrophy Sebastian James Crutch et al. · Alzheimer s & Dementia Open access Mar 2017 679
28 The Fundamentals of Person-Centered Care for Individuals With Dementia Sam Fazio, Douglas D. Pace, Janice Flinner et al. · The Gerontologist Open access 12 Sep 2017 673
29 Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers Giovanni Battista Frisoni et al. · The Lancet Neurology Open access 11 Jul 2017 646
30 The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease Oskar Hansson, Rebecca M. Edelmayer, Adam L. Boxer et al. · Alzheimer s & Dementia Open access 31 Jul 2022 626
31 Vascular contributions to cognitive impairment and dementia including Alzheimer's disease Heather M. Snyder, Roderick A. Corriveau, Suzanne Craft et al. · Alzheimer s & Dementia Open access 12 Dec 2014 624
32 Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report Joseph F. Arboleda‐Velásquez et al. · Nature Medicine Open access Nov 2019 621
33 Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions Vivianna M. Van Deerlin et al. · Nature Genetics Open access100 authors 14 Feb 2010 618
34 Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference Alexandra L. Young et al. · Nature Communications Open access380 authors 9 Oct 2018 613
35 Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association Keith A. Johnson, Satoshi Minoshima, Nicolaas Ida Bohnen et al. · Alzheimer s & Dementia Open access 2013 609
36 Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons Winnie S. Liang, Eric M. Reiman, Jon Valla et al. · Proceedings of the National Academy of Sciences Open access 10 Mar 2008 598
37 Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting Cyndy B. Cordell, Soo Borson, Malaz A. Boustani et al. · Alzheimer s & Dementia Open access 20 Dec 2012 590
38 Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease Jacob W. Vogel et al. · Nature Communications Open access359 authors 26 May 2020 568
39 Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease Michael F. Egan, James T. Kost, Tiffini Voss et al. · New England Journal of Medicine Open access 10 Apr 2019 561
40 Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study Eric M. Reiman et al. · The Lancet Neurology Open access 5 Nov 2012 560
41 World‐Wide FINGERS Network: A global approach to risk reduction and prevention of dementia Miia Kivipelto et al. · Alzheimer s & Dementia Open access Jul 2020 552
42 Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need Ganesh Muneshwar Babulal et al. · Alzheimer s & Dementia Open access 13 Dec 2018 551
43 The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core William J. Jagust, Dan Bandy, Kewei Chen et al. · Alzheimer s & Dementia Open access May 2010 546
44 Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias Gaël Chételat et al. · The Lancet Neurology Open access 21 Oct 2020 545
45 APOE4/4 is linked to damaging lipid droplets in Alzheimer’s disease microglia Michael Seamus Haney et al. · Nature Open access 13 Mar 2024 532
46 Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study Eric M. Reiman et al. · Nature Communications Open access192 authors 3 Feb 2020 513
47 A survey of genetic human cortical gene expression Amanda L. Myers et al. · Nature Genetics 4 Nov 2007 493
48 GAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 Carriers Eric M. Reiman et al. · Neuron Open access Jun 2007 486
49 Contribution of chronic diseases to disability in elderly people in countries with low and middle incomes: a 10/66 Dementia Research Group population-based survey Renata Sousa, Cleusa P. Ferri, Daisy Acosta et al. · The Lancet Open access Nov 2009 482
50 Positron Emission Tomography Imaging With [ 18 F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes Adam Fleisher et al. · JAMA Neurology Open access 27 Apr 2020 462

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.